Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules (Q46946868)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2007

Language	Label	Description	Also known as
English	Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules	scientific article published in December 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hiroaki Nagano

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Atsushi Miyamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Hiroshi Wada

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Hideo Ota

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Shigeru Marubashi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Yutaka Takeda

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Keizo Dono

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Koji Umeshita

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Masato Sakon

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Morito Monden

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

110

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

2493-2501

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrahepatic chemotherapy for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-fu and interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Pilot Study of Intrahepatic Arterial Chemotherapy with Methotrexate, 5-Fluorouracil, Cisplatin and Subcutaneous Interferon-Alpha-2b for Patients with Locally Advanced Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

The human interferon alpha/beta receptor: characterization and molecular cloning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine triggered molecular pathways that control cell cycle arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23033

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17941012

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46946868&oldid=2139394433"